vs

Side-by-side financial comparison of HARROW, INC. (HROW) and ZIPRECRUITER, INC. (ZIP). Click either name above to swap in a different company.

ZIPRECRUITER, INC. is the larger business by last-quarter revenue ($111.7M vs $89.1M, roughly 1.3× HARROW, INC.). HARROW, INC. runs the higher net margin — 7.4% vs -0.7%, a 8.2% gap on every dollar of revenue. On growth, HARROW, INC. posted the faster year-over-year revenue change (33.3% vs 0.6%). HARROW, INC. produced more free cash flow last quarter ($8.1M vs $7.6M). Over the past eight quarters, HARROW, INC.'s revenue compounded faster (60.5% CAGR vs -4.4%).

Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.

HROW vs ZIP — Head-to-Head

Bigger by revenue
ZIP
ZIP
1.3× larger
ZIP
$111.7M
$89.1M
HROW
Growing faster (revenue YoY)
HROW
HROW
+32.7% gap
HROW
33.3%
0.6%
ZIP
Higher net margin
HROW
HROW
8.2% more per $
HROW
7.4%
-0.7%
ZIP
More free cash flow
HROW
HROW
$459.0K more FCF
HROW
$8.1M
$7.6M
ZIP
Faster 2-yr revenue CAGR
HROW
HROW
Annualised
HROW
60.5%
-4.4%
ZIP

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HROW
HROW
ZIP
ZIP
Revenue
$89.1M
$111.7M
Net Profit
$6.6M
$-835.0K
Gross Margin
79.3%
89.1%
Operating Margin
17.5%
3.6%
Net Margin
7.4%
-0.7%
Revenue YoY
33.3%
0.6%
Net Profit YoY
-2.2%
92.3%
EPS (diluted)
$0.20
$-0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HROW
HROW
ZIP
ZIP
Q4 25
$89.1M
$111.7M
Q3 25
$71.6M
$115.0M
Q2 25
$63.7M
$112.2M
Q1 25
$47.8M
$110.1M
Q4 24
$66.8M
$111.0M
Q3 24
$49.3M
$117.1M
Q2 24
$48.9M
$123.7M
Q1 24
$34.6M
$122.2M
Net Profit
HROW
HROW
ZIP
ZIP
Q4 25
$6.6M
$-835.0K
Q3 25
$1.0M
$-9.8M
Q2 25
$5.0M
$-9.5M
Q1 25
$-17.8M
$-12.8M
Q4 24
$6.8M
$-10.8M
Q3 24
$-4.2M
$-2.6M
Q2 24
$-6.5M
$7.0M
Q1 24
$-13.6M
$-6.5M
Gross Margin
HROW
HROW
ZIP
ZIP
Q4 25
79.3%
89.1%
Q3 25
75.3%
89.1%
Q2 25
74.5%
89.3%
Q1 25
67.5%
89.4%
Q4 24
78.8%
89.6%
Q3 24
75.6%
89.4%
Q2 24
74.4%
89.5%
Q1 24
69.5%
89.1%
Operating Margin
HROW
HROW
ZIP
ZIP
Q4 25
17.5%
3.6%
Q3 25
20.6%
-4.4%
Q2 25
17.9%
-5.9%
Q1 25
-23.5%
-10.6%
Q4 24
19.3%
-3.6%
Q3 24
2.7%
-2.8%
Q2 24
3.1%
7.6%
Q1 24
-20.0%
-0.7%
Net Margin
HROW
HROW
ZIP
ZIP
Q4 25
7.4%
-0.7%
Q3 25
1.4%
-8.5%
Q2 25
7.8%
-8.5%
Q1 25
-37.2%
-11.7%
Q4 24
10.1%
-9.7%
Q3 24
-8.6%
-2.2%
Q2 24
-13.2%
5.7%
Q1 24
-39.2%
-5.3%
EPS (diluted)
HROW
HROW
ZIP
ZIP
Q4 25
$0.20
$-0.03
Q3 25
$0.03
$-0.11
Q2 25
$0.13
$-0.10
Q1 25
$-0.50
$-0.13
Q4 24
$0.19
$-0.10
Q3 24
$-0.12
$-0.03
Q2 24
$-0.18
$0.07
Q1 24
$-0.38
$-0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HROW
HROW
ZIP
ZIP
Cash + ST InvestmentsLiquidity on hand
$72.9M
$188.0M
Total DebtLower is stronger
$250.0M
Stockholders' EquityBook value
$52.4M
$-77.2M
Total Assets
$399.5M
$569.7M
Debt / EquityLower = less leverage
4.77×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HROW
HROW
ZIP
ZIP
Q4 25
$72.9M
$188.0M
Q3 25
$74.3M
$211.8M
Q2 25
$53.0M
$203.5M
Q1 25
$66.7M
$221.1M
Q4 24
$47.2M
$218.4M
Q3 24
$72.6M
$225.6M
Q2 24
$71.0M
$271.7M
Q1 24
$76.0M
$282.5M
Total Debt
HROW
HROW
ZIP
ZIP
Q4 25
$250.0M
Q3 25
$347.2M
Q2 25
$250.6M
Q1 25
$256.9M
Q4 24
$262.7M
Q3 24
$230.7M
Q2 24
$236.3M
Q1 24
$243.4M
Stockholders' Equity
HROW
HROW
ZIP
ZIP
Q4 25
$52.4M
$-77.2M
Q3 25
$47.0M
$-76.1M
Q2 25
$49.7M
$-65.9M
Q1 25
$56.5M
$-11.3M
Q4 24
$69.7M
$13.4M
Q3 24
$58.0M
$13.6M
Q2 24
$58.5M
$24.4M
Q1 24
$60.6M
$12.7M
Total Assets
HROW
HROW
ZIP
ZIP
Q4 25
$399.5M
$569.7M
Q3 25
$363.1M
$573.6M
Q2 25
$345.0M
$592.4M
Q1 25
$364.2M
$629.4M
Q4 24
$389.0M
$664.1M
Q3 24
$351.5M
$652.0M
Q2 24
$306.6M
$665.3M
Q1 24
$295.5M
$662.4M
Debt / Equity
HROW
HROW
ZIP
ZIP
Q4 25
4.77×
Q3 25
7.39×
Q2 25
5.05×
Q1 25
4.55×
Q4 24
3.77×
Q3 24
3.98×
Q2 24
4.04×
Q1 24
4.02×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HROW
HROW
ZIP
ZIP
Operating Cash FlowLast quarter
$8.4M
$7.7M
Free Cash FlowOCF − Capex
$8.1M
$7.6M
FCF MarginFCF / Revenue
9.1%
6.8%
Capex IntensityCapex / Revenue
0.4%
0.1%
Cash ConversionOCF / Net Profit
1.27×
TTM Free Cash FlowTrailing 4 quarters
$43.0M
$9.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HROW
HROW
ZIP
ZIP
Q4 25
$8.4M
$7.7M
Q3 25
$16.6M
$2.6M
Q2 25
$-803.0K
$10.5M
Q1 25
$19.7M
$-9.9M
Q4 24
$-17.8M
$12.5M
Q3 24
$3.0M
$9.3M
Q2 24
$-2.7M
$21.9M
Q1 24
$-4.6M
$2.0M
Free Cash Flow
HROW
HROW
ZIP
ZIP
Q4 25
$8.1M
$7.6M
Q3 25
$16.4M
$2.2M
Q2 25
$-969.0K
$10.2M
Q1 25
$19.5M
$-10.2M
Q4 24
$-18.3M
$12.0M
Q3 24
$2.3M
$9.2M
Q2 24
$-3.1M
$21.7M
Q1 24
$-4.7M
$1.9M
FCF Margin
HROW
HROW
ZIP
ZIP
Q4 25
9.1%
6.8%
Q3 25
22.9%
1.9%
Q2 25
-1.5%
9.1%
Q1 25
40.8%
-9.3%
Q4 24
-27.4%
10.8%
Q3 24
4.8%
7.8%
Q2 24
-6.3%
17.6%
Q1 24
-13.6%
1.6%
Capex Intensity
HROW
HROW
ZIP
ZIP
Q4 25
0.4%
0.1%
Q3 25
0.3%
0.3%
Q2 25
0.3%
0.3%
Q1 25
0.4%
0.3%
Q4 24
0.8%
0.4%
Q3 24
1.2%
0.2%
Q2 24
0.7%
0.1%
Q1 24
0.3%
0.1%
Cash Conversion
HROW
HROW
ZIP
ZIP
Q4 25
1.27×
Q3 25
16.26×
Q2 25
-0.16×
Q1 25
Q4 24
-2.62×
Q3 24
Q2 24
3.12×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HROW
HROW

Segment breakdown not available.

ZIP
ZIP

License$84.3M75%
Services$27.4M25%

Related Comparisons